Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Cash from Financing Activities (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed Cash from Financing Activities for 16 consecutive years, with $3.2 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Cash from Financing Activities fell 17.89% year-over-year to $3.2 million, compared with a TTM value of $3.5 million through Jun 2025, down 6.88%, and an annual FY2023 reading of -$5.1 million, down 497.58% over the prior year.
  • Cash from Financing Activities was $3.2 million for Q2 2025 at SRx Health Solutions, up from -$1.2 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $34.4 million in Q3 2021 and bottomed at -$4.6 million in Q2 2023.
  • Average Cash from Financing Activities over 5 years is $2.3 million, with a median of -$95500.0 recorded in 2023.
  • The sharpest move saw Cash from Financing Activities tumbled 1934.67% in 2023, then surged 3509.33% in 2024.
  • Year by year, Cash from Financing Activities stood at -$552000.0 in 2021, then fell by 1.63% to -$561000.0 in 2022, then surged by 41.53% to -$328000.0 in 2023, then tumbled by 982.32% to -$3.6 million in 2024, then surged by 188.85% to $3.2 million in 2025.
  • Business Quant data shows Cash from Financing Activities for SRXH at $3.2 million in Q2 2025, -$1.2 million in Q1 2025, and -$3.6 million in Q4 2024.